AK

Alex Kharazi

Chief Technology Officer

Stemedica Cell Technologies

San Diego, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Stemedica Cell Technologies
Industry
research
Employees
33.0
Seniority
C suite
Annual Revenue
8000000.0
Total Funding
22000000.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Mobile Friendly WordPress.org Google Tag Manager Google Analytics Google Font API Remote

Keywords

biotechnology life sciences biotechnology research stem cells biopharmaceutical progenitor cells clinical trials ischemia-tolerant mesenchymal stem cells alzheimers disease fda approved cell therapy allogeneic cells cell manufacturing cgmp compliant hypoxic environment immune privilege clinical-stage therapeutics medical conditions growth factors neural stem cells chronic ischemic stroke safe treatment blood vessel growth sdf-1 cytokines clinical pipeline production scale research institutions patient care quality control potency testing cell purity independent testing fda guidance treatment efficacy neurodegenerative diseases chronic diseases therapy commercialization disease pathways hla-dr expression intellectual property scientific discovery cell culture therapeutic applications process optimization patient enrollment clinical outcomes global distribution collaboration efforts advanced manufacturing health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans